PeptidePrices safety rating
3/10 · Not FDA-approved
4 vendors · 2 with an issuer-verified COA · lowest 10mg from $72.99 · checked
| Vendor | Price | Actions |
|---|---|---|
| $72.9910mg packageChecked Sep 30 | Buy Dermorphin from Peptides Lab UK | |
| $77.562 × 5mg packages · 10mg totalChecked today | Buy Dermorphin from Kensington Labs | |
| 3-test panelVerified COABioViridian · Tested Jul 30, 2026 | $84.0010mg packageChecked today | Buy Dermorphin from StrikePoint Peptides |
| 6-test panelVerified COABioSyn Systems · Tested Mar 25, 2026 | $207.98 | Buy Dermorphin from Cenexa Labs |
Tracked every day
The five cheapest in-stock package prices for Dermorphin on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
Vendors most often in the cheapest five
Current market data
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for Dermorphin is $72.99 from Peptides Lab UK. The median across vendors is $80.78.
PeptidePrices found 5 in-stock listings from 4 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 10% below the vendor median of $80.78; 2 vendors (50%) fall below that median. 4 of 4 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
3/10 · Not FDA-approved
Natural heptapeptide from frog skin; potent μ-opioid receptor agonist (30-40x more potent than morphine); D-amino acid backbone provides metabolic stability.
Pain management (research); opioid receptor research; analgesic studies. Banned in horse racing due to performance enhancement.
Research / preclinical only
Longer than morphine due to D-amino acids. Variable.
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Opioid side effects: respiratory depression, dependence, tolerance, constipation, sedation. High abuse potential. Not for human therapeutic use.
Potent mu-opioid agonist; respiratory depression risk; used illegally in horse racing; proven opioid dangers Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Related pages